Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 12, 2001, Pages 3531-3537

  Siaperas, P ^a   Pefanis, A ^a   Iliopoulos, D ^a   Katsarolis, I ^a   Kyroudi Voulgari, A ^a   Donta, I ^a   Karayiannakos, P ^a   Giamarellou, H ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; METICILLIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA VALVE DISEASE; ARTICLE; BACTERIAL ENDOCARDITIS; DISEASE SEVERITY; DRUG EFFECT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; AORTIC VALVE; DEXAMETHASONE; DRUG THERAPY, COMBINATION; ENDOCARDITIS, BACTERIAL; FEMALE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; RABBITS; SEPSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURVIVAL ANALYSIS; VANCOMYCIN;

EID: 0035185194     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.12.3531-3537.2001     Document Type: Article

References (36)

1. Three-year multicenter surveillance of pneumococcal meningitis in children: Clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use
2. Pathogenic effects of monocytopenia, granulocytopenia, and dexamethasone on the course of experimental Pseudomonas aeruginosa endocarditis in rabbits
3. Valve site-specific pathogenic differences between right-sided and left-sided bacterial endocarditis
4. Left-sided valvular infective endocarditis. A study of 45 necropsy patients
5. Experimental bacterial endocarditis. IV. Structure and evolution of very early lesions
6. Infective endocarditis due to Staphylococcus aureus: 59 Prospectively identified cases with follow-up
7. Effects of dexamethasone on the profile of cytokine secretion in human whole blood cell cultures
8. Streptococcal infection of endocardial and other intravascular vegetations in rabbits: Natural history and effect of dexamethasone
9. Factors secreted by untreated and hydrocortisone-treated monocytes that modulate neutrophil function
10. Treatment of Staphylococcus aureus catheter-related infection and infective endocarditis with granulocyte colony-stimulating factor in the experimental rabbit model
11. Glucocorticoids dose-dependently increase plasma levels of granulocyte colony-stimulating factor
12. Staphylococcus aureus prosthetic valve endocarditis: Optimal management and risk factors for death
13. Fluorescence polarization immunoassay for the determination of therapeutic levels in human plasma
14. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988
15. Role of granulocytes in experimental Streptococcus sanguis endocarditis
16. Role of granulocytes and monocytes in experimental Staphylococcus epidermidis endocarditis
17. Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis
18. Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart
19. Prevention of hearing loss in experimental pneumococcal meningitis by administration of dexamethasone and ketorolac
20. Reversible neutrophil defect in patients with bacterial endocarditis
21. A study of 47 bacteremic Staphylococcus aureus endocarditis cases: 23 With native valves treated surgically and 24 with prosthetic valves
22. Addition of corticosteroids to antibiotic treatment ameliorates the course of experimental Staphylococcus aureus arthritis
23. Increased frequency of staphylococcal infective endocarditis: Experience at a university hospital, 1981 through 1988
24. Treatment of experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis with intravitreal vancomycin and intravitreal dexamethasone
25. Adhesion molecules (E-selectin, intracellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1)) in sera from patients with Staphylococcus aureus bacteraemia with or without endocarditis
26. Dexamethasone in the treatment of Haemophilus influenzae type b meningitis
27. Arthritis and sepsis caused by Staphylococcus aureus: Can the tissue injury be reduced by modulating the host's immune system?
28. Issues in the management of bacterial meningitis
29. Role of monocytes in experimental Staphylococcus aureus endocarditis
30. Beneficial effect of glucocorticoids on the course of haematogenously acquired Staphylococcus aureus nephritis
31. Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus
32. Infective endocarditis: Ten-year review of medical and surgical therapy
33. Infective endocarditis at a large community hospital, 1980-1990: A review of 210 episodes
34. Comparative efficacies of liposomal amikacin (MiKasome) plus oxacillin versus conventional amikacin plus oxacillin in experimental endocarditis induced by Staphylococcus aureus: Microbiological and echocardiographic analyses
35. Timing of dexamethasone treatment in experimental Staphylococcus aureus endophthalmitis
36. Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: Effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis